West Pharmaceutical Services Inc

WST: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|q$LOCK|w<LOCK|$^!GFTs

West Pharmaceutical Earnings: Another Strong Quarter and Upward Guidance Revision

West reported year-on-year organic revenue growth of 12.7% and adjusted diluted earnings per share growth of 29% for the quarter. Guidance for 2026 was revised upward to 10.5% organic revenue growth and 23% adjusted diluted EPS growth at the midpoints.

Sponsor Center